Healthcare firm Orbimed Asia will invest USD 42.5 million in Vivimed Labs's subsidiary UQUIFA. In an interview to CNBC-TV18, Santosh Varalwar, CMD of Vivimed Labs spoke at length about the same.
Pharmaceutical company, Vivimed Labs, has recently acquired Uquifa, a Spanish pharma company, for USD 55 million so as to expand business operations.